🇺🇸 FDA

Intelligence · Patent portfolio

Axsome Therapeutics Patents

Full USPTO pharma patent portfolio for Axsome Therapeutics — grant dates, expiration, and drug cross-links.

Patents
162
Expiring ≤24m
0

Quick answer

Axsome Therapeutics has 162 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Page 1 of 4

  1. US 12390419

    Formulations of (R)-2-amino-3-phenylpropyl carbamate

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12384743

    Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12370196

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12357697

    Pharmaceutical compositions comprising bupropion and cysteine

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12357640

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12318362

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12268693

    Pharmaceutical compositions comprising a tolfenamic acid

    Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12263145

    Methods of administering solriamfetol to lactating women

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12246023

    Use of reboxetine to treat narcolepsy

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12201601

    Treatment for obesity

    Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12194016

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12162821

    Treatment of cataplexy

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12156914

    Pharmaceutical compositions comprising bupropion and cysteine

    Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 12128052

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 12115165

    Use of reboxetine to treat narcolepsy

    Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 12102609

    Methods of administering solriamfetol to lactating women

    Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 12102606

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 12090126

    Methods of administering solriamfetol to lactating women

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 12064411

    Methods of administering solriamfetol to lactating women

    Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 12036194

    Methods of administering solriamfetol to lactating women

    Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 12005036

    Methods of administering solriamfetol to lactating women

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 12005118

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11998639

    Formulations of (R)-2-amino-3-phenylpropyl carbamate

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11998552

    Pharmaceutical compositions comprising meloxicam

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11986455

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11986454

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11969404

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11957686

    Compositions for delivery of reboxetine

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11944683

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11883408

    Reboxetine to treat narcolepsy

    Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11872204

    Methods of administering solriamfetol to lactating women

    Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11872203

    Methods of administering solriamfetol to lactating women

    Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11865098

    Methods and compositions for treating excessive sleepiness

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11865117

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11857528

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11850228

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11850227

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11850226

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11839598

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11839599

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11826354

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11826370

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11806354

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11801250

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11793776

    Methods of administering solriamfetol to lactating women

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11786488

    Dosage forms and methods for enantiomerically enriched or pure bupropion

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11780805

    Carbamoyl phenylalaninol compounds and uses thereof

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11779554

    Methods of administering solriamfetol to lactating women

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Axsome Therapeutics have?

162 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Axsome Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.